Company:  AEGLEA BIOTHERAPEUTICS, I ... (AGLE)
Form Type:  8-K
Filing Date:  4/21/2017 
CIK:  0001636282 
Address:  901 S. MOPAC EXPRESSWAY, STE. 250
BARTON OAKS PLAZA ONE
 
City, State, Zip:  AUSTIN, Texas 78746 
Telephone:  (512) 942-2935 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$7.87  
Change: 
-0.015 (-0.19%)  
Trade Time: 
01:51 PM EST  
Market Cap: 
$166.50M
Trade AGLE now with 

© 2018  
Description of Business
We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. We believe our novel approach of utilizing human enzymes offers advantages over bacterial enzyme-based approaches including a more favorable safety profile that may provide a greater likelihood of clinical success. Our capabilities in enzyme engineering, preclinical disease modelling, and drug development in both rare genetic disease and cancer allow us to identify and advance innovative opportunities to address important unmet medical needs for the benefit of patients.
Register and access this filing in:     
  FORM 8-K
    SECTION 7 REGULATION FD
      Item 7.01 Regulation FD Disclosure.
    SIGNATURE